Janis Brix

CEO at Wigwam Digital

Janis Brix is a CEO at Wigwam Digital and has been a digital marketeer since 2011, now focusing on life science marketing and strategic business development. He helps life science companies grow by generating traffic and leads through inbound marketing.

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Outsourcing to the right clinical research organization is critical to the smooth-running of any drug development operation. A CRO can be responsible for handling everything from study planning to pharmacovigilance and delays or errors at any stage can cost a significant amount of both money and time. The right CRO can accelerate operations. The wrong one can delay study completion and even jeopardize approval. Delays in patient recruitment, for example, are estimated to cost between $600,000 and $8 million for each day.

Janis Brix

Articles from Janis

How to Choose the Right CRO